An anti-cancer compound developed at USA Health Mitchell Cancer Institute is showing promise in pre-clinical studies – one involving pancreatic cancer and the other involving breast cancer. The compound, MCI-715, was developed by Gary Piazza, Ph.D., and his lab team at the Drug Discovery Research Center at MCI.
The Mission and Vision of USA Health
From the lab to the hospital, from fighting cancer to fighting colds, medicine is ever changing at USA Health. Our culture encourages curiosity and challenges assumptions as we push each other to improve the health of patients. What we discover in the lab, we take to the hospital. What we learn in the classroom, we apply in real life. What goes on behind the scenes directs what goes on in the hallways of our hospitals and in doctors' offices. It’s a culture dedicated to Transforming Medicine™ in every way possible.
We help people lead longer, better lives.
USA Health strives to be the premier integrated, patient-centered healthcare organization in our region. We educate future generations of healthcare providers, and we discover innovative ways to help people become healthier.
Teamwork: We believe a team approach offers the best healthcare for our patients.
Patient-centered: We partner with our patients, their families and their communities.
Quality: We provide the best quality healthcare to our patients.
Respect: We respect our patients and each other.
Service: We strengthen our community and our region through outreach focused on improving health.